Search Criteria
Scheme Search
Microbiology
Specimens
2 simulated samples, 1 mL
Examinations
High-risk human papillomavirus NAT (hrHPVNAT). HPV genotypes included are: 16, 18, 31, 33, 39, 45, 51, 52, 66, 67
Important Notes
Suitable for nucleic acid methods used in cervical cancer screening. The samples contain hDNA. Four rounds per year.
Multiplex
Specimens
3 samples. Either lyophilised mixtures of bacteria and/or simulated samples, 1 mL.
Examinations
Direct nucleic acid detection. Pathogens included are Aeromonas, Campylobacter, E. coli EHEC (stx1/stx2), E. coli EAEC, E. coli EIEC, E. coli EPEC, E. coli ETEC, Plesiomonas, Salmonella, Shigella and Yersinia.
Important Notes
During the period of one calendar year, a comprehensive selection of listed pathogens will be covered.
Microbiology
Specimens
2 lyophilised mixtures of bacteria
Examinations
C. difficile direct nucleic acid detection. Hypervirulent C. difficile strains also included
Important Notes
5200 includes also this examination. Four rounds per year.
Microbiology
Specimens
2 lyophilized samples
Examinations
Direct nucleic acid detection
Important Notes
5220 includes also this examination. For additional set of samples, order scheme 5222. Four rounds per year.
Multiplex
Specimens
4 simulated samples, 1 mL.
Examinations
Direct multiplex nucleic acid detection. Pathogens included are adenovirus, bocavirus, B. parapertussis, B. pertussis, C. pneumoniae, coronavirus (OC43, 229E, NL63, HKU1), enterovirus, influenzavirus A/B, L. pneumophila, metapneumovirus, M. pneumoniae, parainfluenzavirus 1-4, rhinovirus, RSV A/B, SARS-CoV-2 and S. pneumoniae.
Important Notes
During the period of one calendar year, a comprehensive selection of listed pathogens will be covered. The samples contain hDNA.
Multiplex
Specimens
4 simulated swab/urine samples, 2 mL.
Examinations
Direct multiplex nucleic acid detection. Pathogens included are C. trachomatis, M. genitalium, M. hominis, N. gonorrhoeae, T. vaginalis, U. parvum and U. urealyticum.
Important Notes
During the period of one calendar year, a comprehensive selection of listed pathogens will be covered. The samples contain hDNA.
Multiplex
Specimens
3 simulated samples, 1 mL.
Examinations
Direct multiplex nucleic acid detection. Pathogens included are Escherichia coli K1, Haemophilus influenzae, Listeria monocytogenes, Neisseria meningitidis, Streptococcus agalactiae, Streptococcus pneumoniae, Cytomegalovirus (CMV), Enterovirus, Epstein-Barr virus (EBV), Herpes simplex virus 1 (HSV1), Herpes simplex virus 2 (HSV2), Human herpesvirus 6 (HHV6), Human parechovirus (HPeV), Varizella zoster virus (VZV) Cryptococcus neoformans and Cryptococcus gattii.
Important Notes
During the period of one calendar year, a comprehensive selection of listed pathogens will be covered.
Microbiology
Specimens
3 whole blood samples. The scheme contains primarily Plasmodium falciparum positive and negative samples, occasionally other Plasmodium species are included.
Examinations
Antigen and nucleic acid detection. Target antigens: HRP2 and/or pLDH and/or aldolase.
Important Notes
For clinical laboratories and POCT sites.
Multiplex
Specimens
3 lyophilised samples.
Examinations
Nucleic acid detection of Cryptosporidium, Dientamoeba fragilis, Entamoeba histolytica and Giardia lamblia.
Important Notes
Microbiology
Specimens
3 simulated pharyngeal samples
Examinations
Nucleic acid detection
Important Notes
Molecular detection of Group A Streptococcus in pharyngeal samples. Four rounds per year.
Microbiology
Specimens
2 swab samples. Samples also include normal flora
Examinations
Direct nucleic acid detection
Important Notes
The samples contain hDNA. See also product 5594 for S. agalactiae (GBS) culture. Four rounds per year.
Microbiology
Specimens
3 simulated swab/urine samples, 2 mL.
Examinations
Detection of C. trachomatis and N. gonorrhoeae nucleic acid.
Important Notes
See also scheme 5302 Sexually transmitted diseases multiplex, nucleic acid detection. The samples contain hDNA.